Literature DB >> 21102550

A single NFκB system for both canonical and non-canonical signaling.

Vincent Feng-Sheng Shih1, Rachel Tsui, Andrew Caldwell, Alexander Hoffmann.   

Abstract

Two distinct nuclear factor κB (NFκB) signaling pathways have been described; the canonical pathway that mediates inflammatory responses, and the non-canonical pathway that is involved in immune cell differentiation and maturation and secondary lymphoid organogenesis. The former is dependent on the IκB kinase adaptor molecule NEMO, the latter is independent of it. Here, we review the molecular mechanisms of regulation in each signaling axis and attempt to relate the apparent regulatory logic to the physiological function. Further, we review the recent evidence for extensive cross-regulation between these two signaling axes and summarize them in a wiring diagram. These observations suggest that NEMO-dependent and -independent signaling should be viewed within the context of a single NFκB signaling system, which mediates signaling from both inflammatory and organogenic stimuli in an integrated manner. As in other regulatory biological systems, a systems approach including mathematical models that include quantitative and kinetic information will be necessary to characterize the network properties that mediate physiological function, and that may break down to cause or contribute to pathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21102550      PMCID: PMC3193412          DOI: 10.1038/cr.2010.161

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  110 in total

1.  IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation.

Authors:  Toby Lawrence; Magali Bebien; George Y Liu; Victor Nizet; Michael Karin
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

2.  Negative regulation of NF-kappaB signaling by PIAS1.

Authors:  Bin Liu; Randy Yang; Kelly A Wong; Crescent Getman; Natalie Stein; Michael A Teitell; Genhong Cheng; Hong Wu; Ke Shuai
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

3.  Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation.

Authors:  Yoshiteru Sasaki; Emmanuel Derudder; Elias Hobeika; Roberta Pelanda; Michael Reth; Klaus Rajewsky; Marc Schmidt-Supprian
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

4.  Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues.

Authors:  James C Lo; Soumen Basak; Ethan S James; Raechel S Quiambo; Marcus C Kinsella; Maria-Luisa Alegre; Falk Weih; Guido Franzoso; Alexander Hoffmann; Yang-Xin Fu
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

5.  Achieving stability of lipopolysaccharide-induced NF-kappaB activation.

Authors:  Markus W Covert; Thomas H Leung; Jahlionais E Gaston; David Baltimore
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

6.  Stimulus specificity of gene expression programs determined by temporal control of IKK activity.

Authors:  Shannon L Werner; Derren Barken; Alexander Hoffmann
Journal:  Science       Date:  2005-09-16       Impact factor: 47.728

7.  A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation.

Authors:  Shomyseh Sanjabi; Kevin J Williams; Simona Saccani; Liang Zhou; Alexander Hoffmann; Gourisankar Ghosh; Steve Gerondakis; Gioacchino Natoli; Stephen T Smale
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 11.361

8.  RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.

Authors:  Elizabeth G Demicco; Kathryn T Kavanagh; Raphaëlle Romieu-Mourez; Xiaobo Wang; Sangmin R Shin; Esther Landesman-Bollag; David C Seldin; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

9.  Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

Authors:  Chee-Kwee Ea; Li Deng; Zong-Ping Xia; Gabriel Pineda; Zhijian J Chen
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

10.  IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression.

Authors:  Jeffrey D Kearns; Soumen Basak; Shannon L Werner; Christine S Huang; Alexander Hoffmann
Journal:  J Cell Biol       Date:  2006-05-30       Impact factor: 10.539

View more
  179 in total

1.  Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype.

Authors:  Hye Sun Kuehn; Julie E Niemela; Karthik Sreedhara; Jennifer L Stoddard; Jennifer Grossman; Christian A Wysocki; M Teresa de la Morena; Mary Garofalo; Jingga Inlora; Michael P Snyder; David B Lewis; Constantine A Stratakis; Thomas A Fleisher; Sergio D Rosenzweig
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

2.  The non-canonical NF-κB pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro.

Authors:  Kira Meyerovich; Makiko Fukaya; Leticia F Terra; Fernanda Ortis; Decio L Eizirik; Alessandra K Cardozo
Journal:  Diabetologia       Date:  2015-12-03       Impact factor: 10.122

Review 3.  NF-κB signaling in cancer stem cells: a promising therapeutic target?

Authors:  K Vazquez-Santillan; J Melendez-Zajgla; L Jimenez-Hernandez; G Martínez-Ruiz; V Maldonado
Journal:  Cell Oncol (Dordr)       Date:  2015-08-29       Impact factor: 6.730

4.  Inhibition of protein kinase C beta phosphorylation activates nuclear factor-kappa B and improves postischemic recovery in type 1 diabetes.

Authors:  Satyanarayana Alleboina; Thomas Wong; Madhu V Singh; Ayotunde O Dokun
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-23

5.  Role of NADPH oxidase NOX5-S, NF-κB, and DNMT1 in acid-induced p16 hypermethylation in Barrett's cells.

Authors:  Jie Hong; Dan Li; Jack Wands; Rhonda Souza; Weibiao Cao
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-11       Impact factor: 4.249

6.  Hyperoside Suppresses Lipopolysaccharide-induced Inflammation and Apoptosis in Human Umbilical Vein Endothelial Cells.

Authors:  Yan-Qiang Zhou; Yin-Tao Zhao; Xiao-Yan Zhao; Cui Liang; Ya-Wei Xu; Ling Li; Yuan Liu; Hai-Bo Yang
Journal:  Curr Med Sci       Date:  2018-04-30

Review 7.  Cyclin D1, cancer progression, and opportunities in cancer treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  J Mol Med (Berl)       Date:  2016-10-02       Impact factor: 4.599

8.  Silencer-of-Death Domain Mediates Acid-Induced Decrease in Cell Apoptosis in Barrett's Associated Esophageal Adenocarcinoma Cells.

Authors:  Dan Li; Jie Hong; Weibiao Cao
Journal:  J Pharmacol Exp Ther       Date:  2016-10-18       Impact factor: 4.030

9.  Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

Authors:  Orlandric Miree; Sanjeev Kumar Srivastava; Santanu Dasgupta; Seema Singh; Rodney Rocconi; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.

Authors:  Alicia Y Zhou; Rhine R Shen; Eejung Kim; Ying J Lock; Ming Xu; Zhijian J Chen; William C Hahn
Journal:  Cell Rep       Date:  2013-02-28       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.